Suche Medizinische Publikationen
Suche Abbildungen und Grafiken
Medizinprodukte - Labortechnik
Antidotarium (Stand 2012)
Phytokodex (Stand 2012)
Fachbücher
Patientenliteratur
Dia-Präsentation von SERVIER EUROPA-Studie (Perindopril) (60 Abbildungen) Übersicht Gesamtpräsentation zum Download (rechte Maustaste und "Ziel speichern unter..." klicken)
| ||||||||||||||||||
Abbildung 38: EUROPA-Studie - Primärer Endpunkt RRR = relative Risikoreduktion. Perindopril reduced the combined primary endpoint of cardiovascular death, myocardial infarction and cardiac arrest by 20 % (p = 0.0003) after 4 years follow up. Reduction of the primary end-point reached significance even earlier and curves diverged after one year of treatment. |
Abbildung 38: EUROPA-Studie - Primärer Endpunkt
RRR = relative Risikoreduktion. Perindopril reduced the combined primary endpoint of cardiovascular death, myocardial infarction and cardiac arrest by 20 % (p = 0.0003) after 4 years follow up. Reduction of the primary end-point reached significance even earlier and curves diverged after one year of treatment. |